Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter Derivation and Validation of a NECROtizing Soft Tissue Infections (NECROSIS) Score

NCT05224817 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT05224817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05224817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter Derivation and Validation of a NECROtizing Soft Tissue Infections (NECROSIS) Score
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
January 30, 2023
Enrollment
1,010 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

necrosis